The first therapy is finally being used in Germany.
Transcranial Pulse Stimulation (TPS®) is offered by us for outpatients.
Dementia and Alzheimer’s disease, which belongs to the dementia group, have been the focus of increasing scientific research for years. The number of people suffering from dementia is constantly rising and currently stands at around 1.2 million patients in Germany alone. And every year there are about 200,000 more cases. The slowly progressing, but inevitable journey into oblivion, which has not yet been causally treatable, does not only affect the patients themselves. Even the closest relatives, life partners and friends are usually helpless and overwhelmed by the mental and often accompanying physical decline.
Dementia and Alzheimer’s: further research into the causes, but already minimising and stopping the effects today.
Intensive research has been carried out for years on the development of Alzheimer’s or dementia and other related forms of the disease. According to current doctrine, these degenerative diseases cause a disproportionate number of brain cells to die.
Damage to short-term memory is the result, and later the performance of other areas of the brain also decreases. The extent and intensity, the speed of progression of the disease and its effects on everyday life vary greatly from person to person.
Scientifically proven: Transcranial Pulse Stimulation (TPS®) can significantly improve the diseased brain function of the patient.
The internationally renowned Swiss medical technology company STORZ MEDICAL AG, market leader in the field of shock wave therapy for decades, has received approval for the treatment of patients with Alzheimer’s disease with NEUROLITH, the first and so far only system of its kind worldwide.
The NEUROLITH® therapy system generates short, extremely focused sound waves – and these intervene right in the middle of the neuronal processes in the brain. The non-invasive, i.e. externally applied “Transcranial Pulse Stimulation” (TPS®) is completely painless for the patient and takes place in full consciousness. With short, targeted and highly efficient physical energy impulses, applied directly to the skull bone, the affected brain areas are specifically activated. With the help of an integrated real-time documentation system, the brain regions to be stimulated are precisely determined on screen.
After more than ten years of research work, STORZ MEDICAL AG has now been able to prove in a pilot study by the University of Vienna that TPS can stop the continuous decline in the memory performance of Alzheimer’s patients and even improve brain performance.
The Centre for Advanced Medicine in Frankfurt am Main offers TPS as the first practice clinic for patients.
After Transcranial Pulse Stimulation (TPS) has meanwhile proven its worth in countries such as Spain, Austria, China and Hong Kong, it is now also available for outpatients in Germany for the first time.
The treatment is pleasantly painless for the patient and causes no side effects. Six treatments are carried out within two weeks. Each session is expected to last about 30 – 40 minutes. A further six to nine therapy units are recommended over the next 12 months.
Further information can be found on this website at www.erweiterte-medizin.de/en/tps/ and www.tps-neuro.com.
